23rd Annual University of Chicago Developmental Therapeutics Symposium

Chicago, IL US
April 20, 2018
The goals of this activity are to help consortium members assimilate requirements of new studies, review synthesized data from completed studies, discuss the novel investigational agents available from the National Cancer Institute and other sponsors, describe the rational for and results of studies that include new targeted agents for the treatment of patients with advanced and rare disease. This knowledge will enable them to make new treatments available to cancer patients, provide support for current and future oncology clinical trials, and become stronger leaders in the area of oncology research. This program will convey information on how to implement precision medicine in oncology, leading to better outcomes for patients suffering from cancer.

Learning Objectives and Target Audience

At the conclusion of this activity, participants will be able to:

  • State the effects of the use of novel experimental agents from the National Cancer Institute and other sponsors;
  • Cite the relevant pharmacology and biologic effects of novel anti-cancer agents through the use of blood and tissue samples as well as standard and novel imaging approaches;
  • Assess patient suitability for participation in available and upcoming cancer clinical trials and projects;
  • Discuss advances in the use of chemotherapy and other targeted therapies for cancer;
  • Describe the rational for and results of studies that include new targeted agents for the treatment of patients with advanced and rare disease;
  • Summarize how updated regulatory and data operations information can support clinical trial conduct as administrative systems evolve.
This activity has been designed for physicians and other healthcare professionals currently involved in the diagnosis, screening, and treatment of cancer patients.
Additional information
ABMS Core Competencies: 
Medical Knowledge
Systems-based Practice
For more information, please contact:
CME Coordinator Contact Name: 
Mary Sherrell
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
773-702-9856
Summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Participation
Event starts: 
04/20/2018 - 8:00am
Event ends: 
04/20/2018 - 2:40pm
Activity opens: 
04/20/2018
Activity expires: 
07/20/2018

23rd Annual University of Chicago Developmental Therapeutics Symposium Agenda

Gleacher Center
450 N Cityfront Plaza
4th Floor Auditorium
Chicago, IL 60611
United States
Want to know more?
Click here for more information on the Gleacher Center!

 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-702-9856 or via email at msherrell@medicine.bsd.uchicago.edu.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

ACTIVITY DIRECTOR
  Olatoyosi Odenike, MD
  Associate Professor of Medicine
 

 
 
KEYNOTE SPEAKER 
  Michael Bishop, MD
  Professor of Medicine
  Director, Hematopoietic Stem Cell Transplantation Program
 
 
 
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

Accreditation Period

Activity opens: 
04/20/2018
Activity expires: 
07/20/2018

Registration: Click on the button below for more information on how to register!

REGISTER NOW!


Claiming Credit: Enter the access code to unlock the credit claiming process.

 
Please login or create an account to proceed.